title: Impact of physiological BM CD10+CD19+ B-cell precursors (haematogones) in the post-transplant period in patients with AML.
authors.forename: M
authors.initials: M
authors.lastname: Christopeit
authors.forename: A
authors.initials: A
authors.lastname: Heiland
authors.forename: M
authors.initials: M
authors.lastname: Binder
authors.forename: T
authors.initials: T
authors.lastname: Zabelina
authors.forename: F
authors.initials: F
authors.lastname: Ayuk
authors.forename: C
authors.initials: C
authors.lastname: Horn
authors.forename: T
authors.initials: T
authors.lastname: Haferlach
authors.forename: C
authors.initials: C
authors.lastname: Bokemeyer
authors.forename: N
authors.initials: N
authors.lastname: Kröger
authors.forename: U
authors.initials: U
authors.lastname: Bacher
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D018941:Antigens, CD19 / Q000276:immunology*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000276:immunology* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000276:immunology* / Q000601:surgery*; D015260:Neprilysin / Q000276:immunology*; D054448:Precursor Cells, B-Lymphoid / Q000276:immunology*; D055815:Young Adult
chemical_list: D018941:Antigens, CD19; D015260:Neprilysin